Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have temporal lobe epilepsy that has not responded to medication (sometimes called drug-resistant epilepsy).
Who may not be able to join:
- People whose temporal lobe epilepsy is caused by a stroke, reduced blood flow to the brain (ischemia), a type of blood vessel growth called a cavernous angioma, or a type of brain tumour called a meningioma.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: katiuscia Martinello, Biology, Neuromed IRCCS
Phone: 0865915218
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composition of GABA-A receptors that modulate macroscopic currents; Modulation of synaptic transmission by GABA-A receptors PAMs and NAMs; Modulation of inhibitory synaptic transmission by cholinergic, dopaminergic and serotonergic PAMs.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.